Celldex Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Celldex Therapeutics, Inc. (CLDX) reported Earnings Per Share, Basic and Diluted of -$0.45 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-09
- Celldex Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.45.
- Celldex Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.34.
- Celldex Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.42.
- Celldex Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.55.
- Celldex Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.02.
- Celldex Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$3.51.
- Celldex Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$14.48.
- Celldex Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$10.86.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | -$0.45 10-Q · filed 2021-11-09 | -$0.80 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.21 10-Q · filed 2021-11-09 | -$6.30 derived: net income ÷ weighted average shares · filed 2022-11-09 | ||||
| 2021-06-30 | -$0.34 10-Q · filed 2021-08-05 | -$0.76 10-Q · filed 2021-08-05 | -$353.61 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$6.65 derived: net income ÷ weighted average shares · filed 2022-11-09 | ||||
| 2021-03-31 | -$0.42 10-Q · filed 2021-05-06 | $1.96 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1555.59 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$11.48 derived: net income ÷ weighted average shares · filed 2022-11-09 | ||||
| 2020-12-31 | -$0.55 10-K · filed 2021-03-29 | $1.83 derived: net income ÷ weighted average shares · filed 2021-11-09 | $8.12 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$2.02 10-K · filed 2021-03-29 | ||||
| 2020-09-30 | -$0.36 10-Q · filed 2021-11-09 | -$0.82 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$1.44 10-Q · filed 2021-11-09 | -$5.19 derived: net income ÷ weighted average shares · filed 2021-11-09 | ||||
| 2020-06-30 | -$0.50 10-Q · filed 2021-08-05 | -$1.20 10-Q · filed 2021-08-05 | $50.75 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$13.72 derived: net income ÷ weighted average shares · filed 2021-11-09 | ||||
| 2020-03-31 | -$0.73 10-Q · filed 2021-05-06 | $1.91 derived: net income ÷ weighted average shares · filed 2021-11-09 | $11.73 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$36.03 derived: net income ÷ weighted average shares · filed 2021-11-09 | ||||
| 2019-12-31 | -$0.64 10-K · filed 2021-03-29 | $1.67 derived: net income ÷ weighted average shares · filed 2021-03-29 | $8.22 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$3.51 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$0.75 10-K · filed 2021-03-29 | -$1.59 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$2.92 10-Q · filed 2020-11-05 | -$17.41 derived: net income ÷ weighted average shares · filed 2021-03-29 | ||||
| 2019-06-30 | -$0.84 10-K · filed 2021-03-29 | -$2.21 10-Q · filed 2020-08-06 | $30.05 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$25.81 derived: net income ÷ weighted average shares · filed 2021-03-29 | ||||
| 2019-03-31 | -$1.40 10-K · filed 2021-03-29 | $3.00 derived: net income ÷ weighted average shares · filed 2021-03-29 | $14.79 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$68.10 derived: net income ÷ weighted average shares · filed 2021-03-29 | ||||
| 2018-12-31 | -$0.81 10-K · filed 2020-03-26 | $1.74 derived: net income ÷ weighted average shares · filed 2021-03-29 | $10.61 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$14.48 10-K · filed 2021-03-29 | ||||
| 2018-09-30 | -$0.66 10-K · filed 2020-03-26 | -$0.04 10-Q · filed 2018-11-07 | -$2.28 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$14.12 10-Q · filed 2019-11-12 | -$0.94 10-Q · filed 2018-11-07 | $1.86 derived: net income ÷ weighted average shares · filed 2020-03-26 | ||
| 2018-06-30 | -$1.67 10-K · filed 2020-03-26 | -$0.11 10-Q · filed 2018-08-08 | -$14.01 10-Q · filed 2019-08-07 | -$0.93 10-Q · filed 2018-08-08 | $1.28 derived: net income ÷ weighted average shares · filed 2020-03-26 | $3.39 derived: net income ÷ weighted average shares · filed 2020-03-26 | ||
| 2018-03-31 | -$12.61 10-K · filed 2020-03-26 | -$0.84 10-Q · filed 2018-05-10 | $0.73 derived: net income ÷ weighted average shares · filed 2020-03-26 | $2.18 derived: net income ÷ weighted average shares · filed 2020-03-26 | $8.95 derived: net income ÷ weighted average shares · filed 2020-03-26 | |||
| 2017-12-31 | -$0.42 10-K · filed 2019-03-07 | -$0.03 10-K · filed 2018-03-07 | $0.28 derived: net income ÷ weighted average shares · filed 2020-03-26 | $1.99 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$10.86 10-K · filed 2020-03-26 | -$0.72 10-K · filed 2018-03-07 | ||
| 2017-09-30 | -$3.05 10-K · filed 2019-03-07 | -$0.20 10-Q · filed 2017-11-07 | -$0.43 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$0.71 10-Q · filed 2018-11-07 | -$4.57 derived: net income ÷ weighted average shares · filed 2019-03-07 | |||
| 2017-06-30 | -$3.42 10-K · filed 2019-03-07 | -$0.23 10-Q · filed 2017-08-08 | -$0.51 10-Q · filed 2018-08-08 | $12.27 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$6.45 derived: net income ÷ weighted average shares · filed 2019-03-07 | |||
| 2017-03-31 | -$4.19 10-K · filed 2019-03-07 | -$0.28 10-Q · filed 2017-05-09 | $0.90 derived: net income ÷ weighted average shares · filed 2019-03-07 | $6.04 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$10.04 derived: net income ÷ weighted average shares · filed 2019-03-07 | |||
| 2016-12-31 | -$0.30 10-K · filed 2018-03-07 | $0.73 derived: net income ÷ weighted average shares · filed 2019-03-07 | $3.93 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$18.99 10-K · filed 2019-03-07 | -$1.27 10-K · filed 2017-03-14 | |||
| 2016-09-30 | -$0.29 10-K · filed 2018-03-07 | -$0.62 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$0.97 10-Q · filed 2017-11-07 | -$1.30 derived: net income ÷ weighted average shares · filed 2018-03-07 | ||||
| 2016-06-30 | -$0.32 10-K · filed 2018-03-07 | -$0.67 10-Q · filed 2017-08-08 | -$1.01 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.33 derived: net income ÷ weighted average shares · filed 2018-03-07 | ||||
| 2016-03-31 | -$0.35 10-K · filed 2018-03-07 | -$0.68 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.01 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.34 derived: net income ÷ weighted average shares · filed 2018-03-07 | ||||
| 2015-12-31 | -$0.33 10-K · filed 2017-03-14 | -$0.66 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$0.98 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.31 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | -$0.32 10-K · filed 2017-03-14 | -$0.65 derived: net income ÷ weighted average shares · filed 2017-03-14 | -$0.98 10-Q · filed 2016-11-07 | -$1.33 derived: net income ÷ weighted average shares · filed 2017-03-14 | ||||
| 2015-06-30 | -$0.33 10-K · filed 2017-03-14 | -$0.65 10-Q · filed 2016-08-08 | $0.65 10-Q · filed 2015-08-10 | -$1.01 derived: net income ÷ weighted average shares · filed 2017-03-14 | -$1.32 derived: net income ÷ weighted average shares · filed 2017-03-14 | |||
| 2015-03-31 | -$0.33 10-K · filed 2017-03-14 | -$0.68 derived: net income ÷ weighted average shares · filed 2017-03-14 | -$1.00 derived: net income ÷ weighted average shares · filed 2017-03-14 | -$1.31 derived: net income ÷ weighted average shares · filed 2017-03-14 | ||||
| 2014-12-31 | -$0.36 10-K/A · filed 2016-02-25 | -$0.67 derived: net income ÷ weighted average shares · filed 2017-03-14 | -$0.99 derived: net income ÷ weighted average shares · filed 2017-03-14 | -$1.32 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | -$0.31 10-K/A · filed 2016-02-25 | -$0.63 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$0.97 10-Q · filed 2015-11-05 | -$1.23 derived: net income ÷ weighted average shares · filed 2016-02-25 | ||||
| 2014-06-30 | -$0.32 10-K/A · filed 2016-02-25 | -$0.65 10-Q · filed 2015-08-10 | -$0.92 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.21 derived: net income ÷ weighted average shares · filed 2016-02-25 | ||||
| 2014-03-31 | -$0.33 10-K/A · filed 2016-02-25 | -$0.60 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$0.89 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.13 derived: net income ÷ weighted average shares · filed 2016-02-25 | ||||
| 2013-12-31 | -$0.27 10-K · filed 2015-02-24 | -$0.55 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$0.79 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.02 10-K/A · filed 2016-02-25 | ||||
| 2013-09-30 | -$0.29 10-K · filed 2015-02-24 | -$0.52 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$0.76 10-Q · filed 2014-11-05 | -$1.02 derived: net income ÷ weighted average shares · filed 2015-02-24 | ||||
| 2013-06-30 | -$0.24 10-K · filed 2015-02-24 | -$0.47 10-Q · filed 2014-08-07 | -$0.73 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$0.98 derived: net income ÷ weighted average shares · filed 2015-02-24 | ||||
| 2013-03-31 | -$0.23 10-K · filed 2015-02-24 | -$0.50 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$0.75 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$0.99 derived: net income ÷ weighted average shares · filed 2015-02-24 | ||||
| 2012-12-31 | -$0.27 10-K · filed 2014-03-03 | -$0.52 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$0.76 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$1.02 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | -$0.25 10-K · filed 2014-03-03 | -$0.49 derived: net income ÷ weighted average shares · filed 2014-03-03 | -$0.75 10-Q · filed 2013-11-08 | -$1.04 derived: net income ÷ weighted average shares · filed 2014-03-03 | ||||
| 2012-06-30 | -$0.23 10-K · filed 2014-03-03 | -$0.50 10-Q · filed 2013-08-06 | -$0.78 derived: net income ÷ weighted average shares · filed 2014-03-03 | -$1.05 derived: net income ÷ weighted average shares · filed 2014-03-03 | ||||
| 2012-03-31 | -$0.27 10-K · filed 2014-03-03 | -$0.56 derived: net income ÷ weighted average shares · filed 2014-03-03 | -$0.82 derived: net income ÷ weighted average shares · filed 2014-03-03 | -$1.10 derived: net income ÷ weighted average shares · filed 2014-03-03 | ||||
| 2011-12-31 | -$0.29 10-K · filed 2013-03-08 | -$0.55 derived: net income ÷ weighted average shares · filed 2014-03-03 | -$0.83 derived: net income ÷ weighted average shares · filed 2014-03-03 | -$1.13 10-K · filed 2014-03-03 | ||||
| 2011-09-30 | -$0.27 10-K · filed 2013-03-08 | -$0.54 derived: net income ÷ weighted average shares · filed 2013-03-08 | -$0.85 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | -$0.27 10-K · filed 2013-03-08 | -$0.58 10-Q · filed 2012-08-09 | ||||||
| 2011-03-31 | -$0.31 10-K · filed 2013-03-08 | |||||||
| 2010-12-31 | -$0.08 10-K · filed 2013-03-08 | |||||||
| 2010-09-30 | -$0.28 10-Q · filed 2011-11-03 | -$0.79 10-Q · filed 2011-11-03 | ||||||
| 2010-06-30 | -$0.30 10-Q · filed 2011-08-04 | -$0.51 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | -$1.84 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |